Mark Schmidt
Orcid: 0000-0003-3417-8977Affiliations:
- Johnson and Johnson, Janssen Pharmaceutica, Pharmaceutical Research and Development, Beerse, Belgium
- Novartis Pharma AG, Basel, Switzerland
According to our database1,
Mark Schmidt
authored at least 5 papers
between 2007 and 2021.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [<sup>11</sup>C]-ABP688 PET imaging in healthy volunteers.
NeuroImage, 2021
NeuroImage, 2021
2013
NeuroImage, 2013
2010
[18F]JNJ41510417 a potential PET radioligand for imaging phosphodiesterase-10A in the brain.
NeuroImage, 2010
2007
Quantitative evaluation of <sup>11</sup>C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
NeuroImage, 2007